Aridis Pharmaceuticals, Inc. (ARDS) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 15 transactions totaling $181.5K, demonstrating a bullish sentiment with $181.5K in net insider flow. The most recent transaction on Jun 24, 2024 involved a purchase of 714,286 shares valued at $50.0K.
No significant insider buying has been recorded for ARDS in the recent period.
No significant insider selling has been recorded for ARDS in the recent period.
Based on recent SEC filings, insider sentiment for ARDS is bullish with an Insider Alignment Score of 100/100 and a net flow of $181.5K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Aridis Pharmaceuticals, Inc. (ARDS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading ARDS stock, having executed 15 transactions in the past 90 days. The most active insider is Vu Truong (Executive), who has made 3 transactions totaling $75.6K.
Get notified when executives and directors at ARDS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | Truong Vu | Executive | Purchase | 714,286 | $0.07 | $50.0K | |
| Jun 24, 2024 | Patzer Eric | Executive | Purchase | 714,286 | $0.07 | $50.0K | |
| Jun 5, 2023 | Kurland Fred | Executive | Option Exercise | 4,000 | $N/A | $0 | |
| Jun 5, 2023 | Jafri Hasan | Executive | Option Exercise | 10,000 | $N/A | $0 | |
| Jun 5, 2023 | Richards Windham-bannister Susan | Executive | Option Exercise | 5,000 | $N/A | $0 | |
| Jun 5, 2023 | Truong Vu | Executive | Option Exercise | 15,000 | $N/A | $0 | |
| Jun 5, 2023 | F. Hamilton John | Executive | Option Exercise | 5,000 | $N/A | $0 | |
| Jun 5, 2023 | Patzer Eric | Executive | Option Exercise | 12,000 | $N/A | $0 | |
| Sep 7, 2021 | Jafri Hasan | Executive | Purchase | 100 | $3.97 | $397 | |
| Sep 7, 2021 | Jafri Hasan | Executive | Purchase | 1,991 | $4.15 | $8.3K | |
| Sep 3, 2021 | Jafri Hasan | Executive | Purchase | 3,009 | $4.15 | $12.5K | |
| Jul 27, 2021 | Patzer Eric | Executive | Purchase | 5,175 | $4.84 | $25.0K | |
| Jul 27, 2021 | Truong Vu | Executive | Purchase | 5,000 | $5.11 | $25.6K | |
| Jul 27, 2021 | F. Hamilton John | Executive | Purchase | 2,000 | $4.87 | $9.7K | |
| Dec 22, 2020 | Patzer Eric | Executive | Gift | 16,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 8 | $181.5K | 100.0% |
Exercise(M) | 6 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insiders at Aridis Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 6 insiders making 15 transactions totaling $181.5K in purchases versus $0 in sales, the net buying activity of $181.5K signals strong executive confidence. Vu Truong (Executive) leads the buying activity with $75.6K in transactions across all time.